UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

Cancer chemotherapy and pharmacology, 2011-03, Vol.67 (3), p.657-666

2011

Link zum Volltext

Verfügbarkeit prüfen

Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

Cancer, 1999-12, Vol.86 (11), p.2252-2258

1999

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide plus thalidomide in patients with brain metastases from melanoma : A phase II study

Cancer, 2005-06, Vol.103 (12), p.2590-2597

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3351-3356

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical results using biochemotherapy as a standard of care in advanced melanoma

Melanoma research, 2002-08, Vol.12 (4), p.381-387

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment of malignant pleural effusions with tunneled long-term drainage catheters

Journal of vascular and interventional radiology, 2001-02, Vol.12 (2), p.201

2001

Link zum Volltext

Verfügbarkeit prüfen

New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide

Oncology (Williston Park, N.Y.), 2000-12, Vol.14 (12 Suppl 13), p.25

Hwu, W J

2000

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside

Vaccine, 2004-07, Vol.22 (21), p.2904-2909

2004

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding Trial

Journal of clinical oncology, 2002-06, Vol.20 (11), p.2610-2615

2002

Link zum Volltext

Verfügbarkeit prüfen

A clinical-pharmacological evaluation of percutaneous isolated hepatic infusion of doxorubicin in patients with unresectable liver tumors

Oncology research, 1999, Vol.11 (11-12), p.529

1999

Link zum Volltext

Verfügbarkeit prüfen

Sequential Immunization of Melanoma Patients with GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside

Clinical cancer research, 2004-07, Vol.10 (14), p.4717-4723

2004

Link zum Volltext

Verfügbarkeit prüfen

T-Cell responses against tyrosinase 368-376(370D) peptide in HLAA0201+ melanoma patients: Randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants

Clinical cancer research, 2002-05, Vol.8 (5), p.967-972

2002

Link zum Volltext

Verfügbarkeit prüfen

Response of stage IV anal mucosal melanoma to chemotherapy

The lancet oncology, 2005-06, Vol.6 (6), p.438-439

2005

Link zum Volltext

Verfügbarkeit prüfen

Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens

Melanoma research, 2003-12, Vol.13 (6), p.595-601

2003

Link zum Volltext

Verfügbarkeit prüfen

Hypertrophic osteoarthropathy associated with metastatic melanoma

Melanoma research, 2005-12, Vol.15 (6), p.559-561

2005

Link zum Volltext

Verfügbarkeit prüfen

Eruptive melanotic macules and papules associated with adenocarcinoma

Journal of cutaneous pathology, 2003-08, Vol.30 (7), p.463-469

2003

Link zum Volltext

Verfügbarkeit prüfen

Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia

Genes, brain and behavior, 2018-01, Vol.17 (1), p.49-55

2018

Link zum Volltext

Verfügbarkeit prüfen

Minor physical anomalies and craniofacial measures in patients with treatment-resistant schizophrenia

Psychological medicine, 2015-07, Vol.45 (9), p.1839-1850

2015

Link zum Volltext

Verfügbarkeit prüfen

Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue

Translational psychiatry, 2016-01, Vol.6 (1), p.e717-e717

2016

Link zum Volltext

Verfügbarkeit prüfen

Sustained Attention Deficit and Schizotypal Personality Features in Nonpsychotic Relatives of Schizophrenic Patients

The American journal of psychiatry, 1998-09, Vol.155 (9), p.1214-1220

1998

Link zum Volltext

Verfügbarkeit prüfen

Deficits in Sustained Attention in Schizophrenia and Affective Disorders: Stable Versus State-Dependent Markers

The American journal of psychiatry, 2002-06, Vol.159 (6), p.975-982

2002

Link zum Volltext

Verfügbarkeit prüfen

Association of older paternal age with earlier onset among co-affected schizophrenia sib-pairs

Psychological medicine, 2015-07, Vol.45 (10), p.2205-2213

2015

Link zum Volltext

Verfügbarkeit prüfen

Performance of the Continuous Performance Test Among Community Samples

Schizophrenia bulletin, 1998, Vol.24 (1), p.163-174

1998

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis of insulin resistance in hypertensive patients by the metabolic syndrome: AHA vs. IDF definitions

International journal of clinical practice (Esher), 2008-09, Vol.62 (9), p.1441-1446

2008

Link zum Volltext

Verfügbarkeit prüfen

Morbidity Risk of Psychiatric Disorders Among the First Degree Relatives of Schizophrenia Patients in Taiwan

Schizophrenia bulletin, 2002-01, Vol.28 (3), p.379-392

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieInvestigational New Drugs

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(31)
Female
(29)
Life Sciences & Biomedicine
(29)
Male
(29)
Science & Technology
(29)
Adult
(26)
Biological And Medical Sciences
(19)
Medical Sciences
(18)
Aged
(16)
Oncology
(13)
Psychiatry
(12)
Schizophrenia
(11)
Melanoma - Pathology
(8)
Psychology. Psychoanalysis. Psychiatry
(8)
Adolescent
(7)
Aged, 80 And Over
(7)
Dermatology
(7)
Melanoma - Drug Therapy
(7)
Psychopathology. Psychiatry
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

Temozolomide plus thalidomide in patients with brain metastases from melanoma : A phase II study

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Clinical results using biochemotherapy as a standard of care in advanced melanoma

Treatment of malignant pleural effusions with tunneled long-term drainage catheters

New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide

A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside

Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding Trial

A clinical-pharmacological evaluation of percutaneous isolated hepatic infusion of doxorubicin in patients with unresectable liver tumors

Sequential Immunization of Melanoma Patients with GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside

T-Cell responses against tyrosinase 368-376(370D) peptide in HLAA0201+ melanoma patients: Randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants

Response of stage IV anal mucosal melanoma to chemotherapy

Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens

Hypertrophic osteoarthropathy associated with metastatic melanoma

Eruptive melanotic macules and papules associated with adenocarcinoma

Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia

Minor physical anomalies and craniofacial measures in patients with treatment-resistant schizophrenia

Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue

Sustained Attention Deficit and Schizotypal Personality Features in Nonpsychotic Relatives of Schizophrenic Patients

Deficits in Sustained Attention in Schizophrenia and Affective Disorders: Stable Versus State-Dependent Markers

Association of older paternal age with earlier onset among co-affected schizophrenia sib-pairs

Performance of the Continuous Performance Test Among Community Samples

Diagnosis of insulin resistance in hypertensive patients by the metabolic syndrome: AHA vs. IDF definitions

Morbidity Risk of Psychiatric Disorders Among the First Degree Relatives of Schizophrenia Patients in Taiwan

Aktive Filter

Suchergebnisse filtern